Alinidine
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392201This classification denotes an alpha-adrenergic agonist with the molecular formula C12H13Cl2N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7IDJ8DS1D, chemically known as 2-(n-allyl-n-(2,6-dichlorophenyl)amino)-2-imidazoline but generally known as alinidine, which bears US NIH Compound Identifier 36354. Alinidine most often comes in base and hydrobromide forms. European Medicines Agency schedules Alinidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05330MIG. The term ALINIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). ALINIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alinidine under HS 29332990 and SITC 51573. As of Q4 2014, ALINIDINE remains the US FDA Preferred Term for this commodity. Alinidine bears US NLM identifiers UMLS ID C0102151 and NCI Concept Code C72571. SMILES: C=CCN(C1=C(C=CC=C1Cl)Cl)C2=NCCN2.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.